In conversation with... Johannes Schetelig

Listen to The Lancet Haematology

المحتوى المقدم من The Lancet and The Lancet Haematology. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Lancet and The Lancet Haematology أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

4M ago 14:11

MP3•منزل الحلقة

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 22, 2024 01:08 (1M ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia.

49 حلقات

#Science #Podcasting Education #Health and Well-Being #Lancet #Lancet Haematology #Medicine #Research